• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Case Report: Case Series of Kocuria palustris Bacteremia among Immunocompromised Patients
We present three cases of bacteremia in immunocompromised patients admitted to our hospital; one patient was receiving chemotherapy for gall bladder carcinoma, the second was on maintenance hemodialysis for chronic kidney disease, and the third was receiving chemotherapy for acute myeloid leukemia. All three patients presented with a fever in the setting of neutropenia during the course of treatment with chemotherapy (in Cases 1 and 3) or hemodialysis (in Case 2). The blood culture samples of all the patients had pure isolates of Kocuria species K. palustris, which was identified by matrix assisted laser desorption ionisat...
Source: The American Journal of Tropical Medicine and Hygiene - September 18, 2023 Category: Tropical Medicine Authors: Gerlin Varghese Ashima Jamwal Deepika Sarawat Chinmoy Sahu Sangram Singh Patel Nidhi Tejan Source Type: research

Model-Informed Precision Dosing of Vancomycin in Adult Patients Undergoing Hemodialysis
In conclusion, this study demonstrated that KoA-predicted hemodialysis clearance may lead to an upgrade from conventional dosing to MIPD for vancomycin in patients undergoing hemodialysis.PMID:37195225 | DOI:10.1128/aac.00089-23
Source: Antimicrobial Agents and Chemotherapy - May 17, 2023 Category: Microbiology Authors: Kazutaka Oda Hirofumi Jono Hideyuki Saito Source Type: research

Withdrawal from Hemodialysis in a Patient with IgD Type Multiple Myeloma: A Case-based Review
Acta Med Okayama. 2023 Apr;77(2):221-225. doi: 10.18926/AMO/65154.ABSTRACTSeveral previous case reports have shown that patients with immunoglobulin D (IgD) multiple myeloma (MM) can be withdrawn from hemodialysis, however, the characteristics that can predict withdrawal in these patients have not yet been elucidated. A 57-year-old Japanese woman required hemodialysis because of renal dysfunction due to IgD-λ and Bence Jones protein-λ MM. Bortezomib-based chemotherapy nine days after admission led to her withdrawal from hemodialysis on Day 50. In our case-based review, younger age and early initiation of bortezomib-based...
Source: Acta Med Okayama - April 24, 2023 Category: Universities & Medical Training Authors: Hiroki Iriyoshi Ken-Ei Sada Atsushi Miyauchi Hirotaka Yamamoto Daisuke Hashimoto Shigeru Nojima Shingo Yamanaka Masafumi Kawamura Satoshi Oka Source Type: research

Pages: 1  2  3  4  5  6  7  8  9  10